Monday, June 29, 2020

Vivoryon previously known as Probiodrug

Notes June 29/6/2020

Not much sales, seems to have sold shares to finance expenses and increase book value to EUR 2,- Changed name. Price EUR 3,90 

Monday, November 05, 2018

Probiodrug note

2017: Probiodrug loss-making biotech, not a stock for the Defensive Investor
2018: stock price has dropped from EUR 17 to EUR 3,20

Book value per share? Equity has dropped from EUR 9m to 5m in the first half of the year. Could go to zero in the second half of 2018?

No comments: